Deepak R. Jadon

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

The use of combination advanced therapies in psoriatic arthritis: results from a UK multi-centre audit.

The use of combination advanced therapies in psoriatic arthritis: results from a UK multi-centre audit.

Journal: Rheumatology (Oxford, England)

Published: January 14, 2025

The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial.

The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial.

Journal: Therapeutic advances in musculoskeletal disease

Published: November 08, 2023

GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.

GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.

Journal: medRxiv : the preprint server for health sciences

Published: October 24, 2023

GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.

GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.

Journal: Nature communications

Published: October 04, 2023

Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings.

Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings.

Journal: Rheumatology (Oxford, England)

Published: August 16, 2023

The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune-Mediated Inflammatory Disease.

The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune-Mediated Inflammatory Disease.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: July 07, 2023

Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting.

Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting.

Journal: The Journal of rheumatology

Published: May 30, 2023

Proceedings of the GRAPPA 2022 Executive Retreat.

Proceedings of the GRAPPA 2022 Executive Retreat.

Journal: The Journal of rheumatology

Published: May 30, 2023

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials.

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials.

Journal: The Lancet. Rheumatology

Published: April 03, 2023

Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis.

Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis.

Journal: BMJ open

Published: March 24, 2023

Horizon scan: State-of-the-art therapeutics for psoriatic arthritis.

Horizon scan: State-of-the-art therapeutics for psoriatic arthritis.

Journal: Best practice & research. Clinical rheumatology

Published: December 25, 2022

Author Correction: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021.

Author Correction: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021.

Journal: Nature reviews. Rheumatology

Published: October 10, 2022

Showing 1-12 of 65

Last Updated: 09/26/2026